-

SHAREHOLDER ALERT: Robbins LLP Announces That Arcimoto (FUV) is Being Sued for Misleading Shareholders

SAN DIEGO & EUGENE, Ore.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of Arcimoto Inc. (NASDAQ: FUV) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between February 14, 2018 and March 22, 2021. Acrimoto purportedly manufactures ulta-efficient three-wheeled electric vehicle.

If you suffered a loss due to Arcimoto Inc.'s misconduct, click here.

Arcimoto Inc. (FUV) Misled Investors Regarding its Business Operations

According to the complaint, Arcimoto stated in press releases from 2018 to 2020 that they had received 400 preorders for their Fun Utility Vehicle. Arcimoto generated excitement for their vehicles by announcing pilot programs with various entities, including HULA Holdings, GoCar Tours, and Sol Mar Vida. On October 2, 2019, Arcimoto announced its first rental franchise to open in the Florida Keys. Arcimoto subsequently announced a municipal pilot program with the Eugene Springfield Fire Department and the City of Orlando. However, these statements were false and misleading.

On March 23, 2021, Bonitas Research published a report revealing that Arcimoto had misled the investing public by fabricating its preorders. Specifically, the report claims that Arcimoto only delivered 5% if its pre-orders. The report further stated that Arcimoto filed a total production recall notice with the National Highway Traffic Safety Administration on November 18, 2020, but "concealed safety concerns from customers and investors." The report also revealed several related party transactions, specifically with R-Key-Moto the Florida Keys franchise, Wahlbergers Key West, and HULA. On this news, Arcimoto's stock fell approximately 6.56% to close at $15.67 per share on March 23, 2021, damaging investors. The stock has continued to decline and now trades at just over $10 per share.

If you purchased shares of Arcimoto Inc. (FUV) between February 14, 2018 and March 22, 2021, you have until June 18, 2021, to ask the court to appoint you lead plaintiff for the class. If you would like more information regarding your rights, please contact Lauren Levi at (800) 350-6003 or llevi@robbinsllp.com, or via our Shareholder Information Form.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Arcimoto Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Regencell Bioscience Holdings Limited Class Action Reminder - Robbins LLP Encourages RGC Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autis...

POET Technologies Inc. Class Action Reminder - Robbins LLP Encourages POET Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POET Technologies Inc. (NASDAQ: POET) securities between April 1, 2026 and 8:57 A.M. ET on April 27, 2026. POET Technologies describes itself as a "design and development company offering photonic integrated packaging solutions based on the POET Optical Interposer™, a novel platform that allows the seamless integration of electronic and photoni...

Immutep Limited Class Action Reminder - Robbins LLP Encourages IMMP Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating Allegations that Immutep Limited (IMMP) Misled Investors Regarding the Viability and Efficacy of its Drug CandidateOn May 5, 2026, a class action was filed on behalf of all investors who purchased or otherwise acquired Immutep Limited American Depository Receipts (NASDAQ: IMMP) between March 24, 2025 and March 12, 2026. Immutep is an Australian-based biotechnology company focused on developing Lymphocyte Activation Gene-3 (LAG-3) related i...
Back to Newsroom